Comparison between immunogenotypic findings in de novo AML and AML post MDS.

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Comparison between immunogenotypic findings in de novo AML and AML post MDS.

Leukemia - 1 Nov 1993

Ohyashiki J H, Ohyashiki K, Kawakubo K, Fujimura T, Shimamoto T, Nakazawa S, Kimura N, Toyama K

Abstract excerpt

We compared immunogenotypic findings in 73 patients with de novo acute myeloid leukemia (AML) and 30 patients with AML developed in myelodysplastic syndrome (AML post MDS) to determine the biological difference between these hematopoietic neoplasias. Lymphoid-associated antigens were detected in 13 patients with de novo AML, four of whom exhibited rearrangement of the immunoglobulin heavy-chain (IgH) gene. T-cell...

Topics

Adult
Aged
Aged, 80 and over
Antigens, CD
Antigens, CD19
Antigens, CD7
Antigens, Differentiation, B-Lymphocyte
Antigens, Differentiation, T-Lymphocyte
Blotting, Southern
Female
Gene Rearrangement, B-Lymphocyte, Heavy Chain

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Gene Rearrangement, beta-Chain T-Cell Antigen Receptor

Gene Rearrangement, delta-Chain T-Cell Antigen Receptor

Genotype

Humans

Immunophenotyping

Leukemia, Myeloid, Acute

Male

Source

Open in PubMed

Identifiers

PMID: 7694003

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 29 Aug 2026. Prepared record publication-7694003-2026-08-29.1. Manifest publication-graph-cohort-2026-08-29.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 29 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Comparison between immunogenotypic findings in de novo AML and AML post MDS.PMID 7694003Read ↗

Acute lymphoid leukemias following either a previous chronic myelogenous leukemia or myelodysplastic syndrome: phenotypic and genomic differences.Semantic proximity Read ↗

Myelodysplastic/Myeloproliferative NeoplasmsSemantic proximity Read ↗

Myeloid neoplasms in the World Health Organization 2016 classification.Semantic proximity Read ↗

Can molecular patterns help to classify overlapping entities in myeloid neoplasms?Semantic proximity Read ↗

Understanding the Continuum between High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia.Semantic proximity Read ↗

Navigating the contested borders between myelodysplastic syndrome and acute myeloid leukemiaSemantic proximity Read ↗

Clinicopathological characteristics of de novo and secondary myeloid sarcoma: A monocentric retrospective study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.